Search Results for keywords:"pharmaceutical intermediate product"

Found 1 results
Skip to main content

Search Results: keywords:"pharmaceutical intermediate product"

  • Type:Notice
    Citation:90 FR 12294
    Reading Time:about a minute or two

    Pfizer, Inc. has submitted a proposal to the Foreign-Trade Zones Board to allow specific production activities at its Kalamazoo, Michigan facilities within Subzone 43E. This proposal covers the production of a pharmaceutical intermediate product called phthalimido lactol, using a foreign-supplied material, 3 phthalimidopropionaldehyde (3-PPA), both with a duty rate of 6.5%. The foreign component may be subject to certain duties based on its country of origin and must be admitted to the zone in a specific status under U.S. trade regulations. Public comments are invited until April 28, 2025, and further details can be found on the Board's website or by contacting Diane Finver.

    Simple Explanation

    Pfizer wants to make a special ingredient for medicine at a factory in Michigan, and they are asking for permission to do it in a way that helps with taxes on the materials they use. People can say if they think this is a good idea until the end of April.